mayo clinic school of continuous professional development

_______________________________________________________________________________________ Mayo Clinic School of Continuous Professional Development 13400 East Shea Boulevard Scottsdale, Arizona 85259 Telephone: (480) 301-4580

Dear Representative, On behalf of Mayo Clinic’s Division of Gastroenterology and Hepatology and Mayo Clinic School of Continuous Professional Development, we are pleased to announce the “Mayo Clinic Gastroenterology and Hepatology 2019” course will be held February 21-24, 2019 at the Westin Kierland Resort in Scottsdale, Arizona. We invite you and your company to exhibit at this CME activity. The exhibit fee is $4,000. Space is limited; early registration is advised. We expect over 200 gastroenterologists, hepatologists, physician assistants and nurse practitioners from across the United States to attend this course which includes general session didactic presentations supplemented with videos, case presentations, panel discussions, lunch breakout sessions, and use of an interactive audience response system. The course brochure and program schedule is attached for your perusal. As you can see from the enclosed program, we have developed another outstanding course which includes the following topics:

• Hepatology • Pancreatic Disorders • Esophageal Disorders • IBD & Colorectal Neoplasia

• Motility • Complex Endoscopy & ERCP • Small Bowel, Colon and General Gastroenterology

If you will join us, please complete the attached exhibitor agreement and return it with your payment (made payable to Mayo Clinic in Arizona) to Mayo Clinic School of Continuous Professional Development, Attn: Kristy Badder, 13400 East Shea Boulevard, Scottsdale, AZ 85259. Please denote course activity “GI Hep 2019” on all correspondence. Mayo Clinic’s Tax ID number is 86-0800150; our W-9 form is attached for your convenience. The exhibit fee includes a 6’ skirted table for a table top display; attendee list including name, degree, city, state to be distributed at the course; and acknowledgement with signage and announcements during the course. To maintain a clear separation of promotion from education, exhibits will be located adjacent to where the educational sessions will be held. Displays should be staffed during daily breakfast and mid-morning refreshment break; respective times are noted on the attached program. No more than two representatives may be at the display at any time. You may rotate coverage on a daily basis as needed. We hope you will join us in Scottsdale in February! Sincerely, Rahul Pannala, M.D. Consultant, Division of Gastroenterology & Hepatology Assistant Professor of Medicine Mayo Clinic College of Medicine and Science

of 2

Mayo Clinic School of Continuous Professional Development (MCSCPD) Exhibitor Agreement

Agreement between: ACCREDITED PROVIDER: Mayo Clinic College of Medicine and Science – MCSCPD AND:

Company Name (Exhibitor) (as it should appear on printed materials)

Exhibit Contact (if different then exhibit Rep.) Name(s) of Representative(s) exhibiting: (Maximum of two representatives allowed per exhibit)

Address Telephone Fax Email The named exhibitor wishes to exhibit at the above named activity for the amount of $4,000.00

NOTE: There may also be additional charges depending on the meeting location (power, internet access, etc.). Please list additional requests here: (please note: additional requests may incur additional fees)

TERMS AND CONDITIONS

• EXHIBITOR agrees to abide by ACCME Standards for Commercial Support as stated at www.accme.org: SCS 4.2: “Product-promotion material or product-specific advertisement of any type is prohibited in or during CME activities. The juxtaposition of editorial and advertising material on the same products or subjects must be avoided. Live (staffed exhibits, presentations) or enduring (printed or electronic advertisements) promotional activities must be kept separate from CME.” “For live, face-to-face CME, advertisements and promotional materials cannot be displayed or distributed in the educational space immediately before, during or after a CME activity. Providers cannot allow representatives of Commercial Interests to engage in sales or promotional activities while in the space or place of the CME activity.”

• EXHIBITOR may only distribute educational promotional materials at their exhibit space. Distribution of non-educational items (pens, notepads, etc.), pharmaceuticals or product samples is prohibited.

• All exhibit fees associated with this activity will be given with the full knowledge of the PROVIDER. No additional payments, goods, services or events will be provided to the course director(s), planning committee members, faculty, joint provider, or any other party involved with the activity.

• Completion of this agreement represents a commitment and EXHIBITOR is obligated to provide full payment of all amounts due under this agreement by the ACTIVITY DATE unless otherwise agreed upon by the PROVIDER. PROVIDER reserves the right to refuse exhibit space to EXHIBITOR in the event of nonpayment or Code of Conduct violation.

• If this agreement is cancelled by either party forty-five (45) days or more in advance of the Activity Date, PROVIDER will refund the Exhibit Fee less a $300 processing fee. If this agreement is cancelled by EXHIBITOR less than forty-five (45) days in advance of the Activity Date, the total amount due under this Agreement shall be immediately due and payable to PROVIDER.

Activity Title Mayo Clinic Gastroenterology and Hepatology 2019 Activity Number 19S05115 Location Westin Kierland Resort, Scottsdale, AZ Activity Date(s) February 21-24, 2019

of 2 • PROVIDER agrees to provide exhibit space and may acknowledge EXHIBITOR in activity announcements. PROVIDER

reserves the right to assign exhibit space or relocate exhibits at its discretion.

Note: All exhibitors must be approved by MCSCPD and this agreement is not binding until both parties have signed. MCSCPD maintains the right to refuse any exhibitor.

By signing below, I agree to the “Terms and Conditions” outlined on Page 1 of this Exhibitor Agreement (including ACCME Standards for Commercial Support):

The person signing below is authorized to enter into this agreement:

Exhibitor Representative Name Signature Date Mayo Clinic Representative Name Signature Date Kristy Badder

PAYMENT INFORMATION Please indicate your method of payment:

PROVIDER Federal Tax ID number is 86-0800150. Please remit check payable to: Mayo Clinic Arizona. Please identify name of course on the check stub.

☐ Check ☐ Credit Card or Wire Transfer Make payable to Mayo Clinic Arizona and remit to: Mayo Clinic School of Continuous Professional Development Attn: Kristy Badder 13400 East Shea Blvd. Scottsdale, AZ 85259 Please identify course Activity #19S05115 on the check.

For payment by credit card or wire transfer, please call the MCSCPD Registrar at 480-301-4580 Do not send credit card information via email or fax.

Complete and return this form along with your payment made to Mayo Clinic Arizona, Federal Tax ID# 86-0800150 :

Mayo Clinic School of Continuous Professional Development

Attn: Kristy Badder 13400 East Shea Blvd. Scottsdale, AZ 85259

T: 480-301-4580 F: 480-301-9161

Mayo Clinic Gastroenterology & Hepatology 2019 Program Schedule

Thursday, February 21, 2019

7:00 a.m. Registration, Continental Breakfast and Exhibits

7:45 a.m. Welcome & Introductions

Rahul Pannala, M.D.

SESSION I - LIVER 1 MODERATOR: Hugo E. Vargas, M.D. 8:00 a.m. Drug Induced Liver Injury: Common Culprits

John J. Poterucha, M.D.

8:20 a.m. HCV: Treatment Update 2019 Hugo E. Vargas, M.D.

8:40 a.m. NAFLD: Biopsy or Not? William C. Palmer, M.D.

9:00 a.m. Alcoholic Hepatitis: Management Strategies Vijay H. Shah, M.D.

9:20 a.m. Case Presentations and Discussion Faculty

9:40 a.m. Q & A Faculty

10:00 a.m. Refreshment Break and Exhibits

SESSION II - Liver 2 MODERATOR: Harmeet Malhi, M.B.B.S. 10:20 a.m. Cirrhosis: Preventive Care

Elizabeth J. Carey, M.D.

10:40 a.m. Evaluation of the Incidental Liver Mass William Sanchez, M.D.

11:00 a.m. Managing Hepatocellular Cancer: Ablation and Other Options Denise M. Harnois, D.O.

Thursday, February 21, 2019 (continued)

11:20 a.m. Hilar Cholangiocarcinoma: Evaluation and Management

Harmeet Malhi, M.B.B.S.


Noon Q & A Faculty

12:20 p.m. Travel to Lunch Sessions

12:35 p.m. Concurrent Lunch Session (select one session)

a) PBC & PSC: Cases from the Liver Clinic Elizabeth J. Carey, M.D. & Harmeet Malhi, M.B.B.S.

b) Approach to Abnormal LFTs

William Sanchez, M.D. & Denise M. Harnois, D.O.

c) Gluten Sensitivity and Celiac Disease Lucinda A. Harris, M.D. & Stephanie L. Hansel, M.D., M.S.

d) Esophageal Stricture Management: From the Simple to the Complex Prasad G. Iyer, M.D. & Rahul Pannala, M.D.

1:35 p.m. Adjourn

5:30 p.m. Welcome Reception

Friday, February 22, 2019 7:00 a.m. Continental Breakfast and Exhibits

7:45 a.m. Announcements

SESSION III - PANCREATIC DISORDERS MODERATOR: Suresh T. Chari, M.D. 8:00 a.m. Pancreatic Cysts:

Translating Guidelines into Practice Rahul Pannala, M.D.

8:20 a.m. Chronic Pancreatitis: Management of Complex Patients Suresh T. Chari, M.D.

8:40 a.m. Imaging in Pancreatic Disorders: A Case-Based Overview Kumaresan Sandrasegaran, M.B., Ch.B.

9:00 a.m. Pancreatic Cancer Surgery in the Neoadjuvant Era Mark J. Truty, M.D., M.S.


9:40 a.m. Q & A

Faculty


SESSION IV - ESOPHAGEAL DISORDERS MODERATOR: Marcelo F. Vela, M.D. 10:20 a.m. Current Evaluation and Management of Achalasia

Marcelo F. Vela, M.D.

10:40 a.m. Barrett’s Esophagus: Pearls and Pitfalls in Diagnosis and Management Prasad G. Iyer, M.D.

11:00 a.m. Eosinophilic Esophagitis: Drugs, Diet or Dilation Jennifer L. Horsley-Silva, M.D.

11:20 a.m. Managing Risks and Benefits of PPI Therapy Kenneth R. DeVault, M.D.

Friday, February 22, 2019 (continued) 11:40 a.m. Case Presentations and Discussion

Faculty

Noon Q & A Faculty



e) Advanced Practice Providers Session: Chronic Disease Management in IBD and Cirrhosis: Best Practices in Outpatient Management Bridget A. Howard, A.P.R.N., C.N.P., M.S.N., Shari T. Perez, D.N.P., M.S.N., A.N.P.-C., & David E. Payton, M.A., M.M.S., P.A.-C.

f) Approach to Abnormal LFTs

William Sanchez, M.D. & Denise M. Harnois, D.O.

g) Challenging Cases from the Motility Clinic Magnus Halland, M.D. & Brian E. Lacy, M.D., Ph.D.

h) Necrotizing Pancreatitis: Medical and Endoscopic Management of Challenging Cases Suresh T. Chari, M.D. & Douglas O. Faigel, M.D.

1:35 p.m. Adjourn

Saturday, February 23, 2019 7:00 a.m. Continental Breakfast and Exhibits


SESSION V - IBD/COLORECTAL NEOPLASIA MODERATOR: Michael F. Picco, M.D., Ph.D. 8:00 a.m. IBD in Pregnancy: What’s Safe and What’s Not?

Laura E. Raffals, M.D.

8:20 a.m. Crohn’s Disease: Medical Management of Refractory and Fistulizing Disease Jonathan A. Leighton, M.D.

8:40 a.m. Dysplasia in IBD: Endoscopic Assessment and Management Michael F. Picco, M.D., Ph.D.

9:00 a.m. Ulcerative Colitis: Biologic Choices in Refractory Patients Talha A. Malik, M.D., M.P.H.



SESSION VI - MOTILITY MODERATOR: Brian E. Lacy, M.D., Ph.D. 10:20 a.m. Diets in GI Diseases: FODMAP and Beyond

Yuri A. Saito, M.D., M.P.H.

10:40 a.m. Practical Approach to Bloating Magnus Halland, M.D.

11:00 a.m. IBS: Evidence-Based Approach to Management Brian E. Lacy, M.D., Ph.D.

11:20 a.m. Constipation: Beyond the Basics Lucinda A. Harris, M.D.


Saturday, February 23, 2019 (continued)

Noon Q & A

Faculty



i) Challenging Cases from the Motility Clinic Magnus Halland, M.D. & Brian E. Lacy, M.D., Ph.D.

j) Inpatient Management of IBD Laura E. Raffals, M.D. & Michael F. Picco, M.D., Ph.D.

k) Colonoscopy and Polypectomy Techniques: Lessons from the Masters Norio Fukami, M.D. & Michael B. Wallace, M.D.

l) Social Media: Best Practices for the GI Practice Shabana F. Pasha, M.D. & Liliana G. Soto

1:35 p.m. Adjourn

Sunday, February 24, 2019 7:00 a.m. Continental Breakfast and Exhibits


SESSION VII - COMPLEX ENDOSCOPY/ERCP MODERATOR: Norio Fukami, M.D. 8:00 a.m. Approach to Difficult Stones and Strictures in ERCP

Frank Lukens, M.D.

8:20 a.m. Endoscopic Hemostasis: New Tools, Tips and Tricks Louis M. Wong Kee Song, M.D.

8:40 a.m. Large Colonic Polyps: EMR, ESD or Surgery? Norio Fukami, M.D.

9:00 a.m. Sessile Polyps: Tips and Tricks for Improved Detection Michael B. Wallace, M.D.

9:20 a.m. Endoscopic Interventions in Pancreatic Cancer: From Diagnosis to Palliation Douglas O. Faigel, M.D.



SESSION VIII - SMALL BOWEL/COLON/GENERAL GI MODERATOR: Stephanie L. Hansel, M.D., M.S. 10:20 a.m. C. Difficile Management in 2019: Vancomycin and Beyond

Darrell S. Pardi, M.D.

10:40 a.m. Obscure Gastrointestinal Bleeding: Step-Wise Approach to Diagnosis and Management Shabana F. Pasha, M.D.

11:00 a.m. Colonic Polyposis Syndromes: An Update for the General Gastroenterologist Niloy Jewel Samadder, M.D.

Sunday, February 24, 2019 (continued) 11:20 a.m. Diarrhea: Think Outside the IBS Box

Stephanie L. Hansel, M.D., M.S.


Noon Q & A

Faculty

12:20 p.m. Closing Comments, Evaluation and Adjourn

mayo clinic school of continuous professional development

Documents